(Q42460536)

1 November 2017

Prognostic factors and recurrence of hepatitis B-related hepatocellular carcinoma after argon-helium cryoablation: a prospective study (English)

1 reference

1 November 2017

hepatocellular carcinoma

1 reference

Chunping Wang

1

1 reference

1 November 2017

Yinying Lu

2

1 reference

1 November 2017

Yan Chen

3

1 reference

1 November 2017

Yongyi Feng

4

1 reference

1 November 2017

Linjing An

5

1 reference

1 November 2017

Xinzhen Wang

6

1 reference

1 November 2017

Shuhui Su

7

1 reference

1 November 2017

Wenlin Bai

8

1 reference

1 November 2017

Lin Zhou

9

1 reference

1 November 2017

Yongping Yang

10

1 reference

1 November 2017

Dongping Xu

11

1 reference

1 November 2017

1 January 2009

1 reference

Clinical & Experimental Metastasis

1 November 2017

1 reference

1 November 2017

26

1 reference

1 November 2017

7

1 reference

1 November 2017

839-848

1 reference

https://scigraph.springernature.com/pub.10.1007/s10585-009-9283-6

1 November 2017

0 references

cites work

Percutaneous cryoablation in combination with ethanol injection for unresectable hepatocellular carcinoma

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10585-009-9283-6

Expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor in hepatocellular carcinoma: Impact on neovascularization and survival

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10585-009-9283-6

Expression of plasma vascular endothelial growth factor in patients with hepatocellular carcinoma and effect of transcatheter arterial chemoembolization therapy on plasma vascular endothelial growth factor level

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10585-009-9283-6

Basal core-promoter mutant of hepatitis B virus and progression of liver disease in hepatitis B e antigen-negative chronic hepatitis B.

21 January 2018

1 reference

12 December 2020

Prognostic factors for long-term outcome after percutaneous thermal ablation for hepatocellular carcinoma: a survival analysis of 137 consecutive patients

1 reference

12 December 2020

Clinical implications of circulating angiogenic factors in cancer patients

1 reference

12 December 2020

Significance of circulating endothelial progenitor cells in hepatocellular carcinoma

1 reference

12 December 2020

Significant long-term survival after radiofrequency ablation of unresectable hepatocellular carcinoma in patients with cirrhosis

1 reference

12 December 2020

VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization

1 reference

12 December 2020

Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis

1 reference

12 December 2020

Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: clinical evidence of platelet scavenging?

1 reference

12 December 2020

Long-term follow-up outcome of patients undergoing radiofrequency ablation for unresectable hepatocellular carcinoma

1 reference

12 December 2020

Hepatitis B virus (HBV) genotypes/subgenotypes in China: mutations in core promoter and precore/core and their clinical implications

1 reference

12 December 2020

Prognostic factors and recurrence of small hepatocellular carcinoma after hepatic resection or microwave ablation: a retrospective study

1 reference

12 December 2020

Clinical significance of hepatic resection in hepatocellular carcinoma: analysis by disease-free survival curves

1 reference

12 December 2020

Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease

1 reference

12 December 2020

Role of hepatitis B virus genotypes Ba and C, core promoter and precore mutations on hepatocellular carcinoma: a case control study.

1 reference

12 December 2020

Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma

1 reference

12 December 2020

Mobilization of endothelial and hematopoietic stem and progenitor cells by adenovector-mediated elevation of serum levels of SDF-1, VEGF, and angiopoietin-1.

1 reference

12 December 2020

Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation.

1 reference

12 December 2020

1 reference

12 December 2020

Long-term tracking of hepatitis B viral load and the relationship with risk for hepatocellular carcinoma in men.

1 reference

12 December 2020

A hepatitis B virus mutant associated with an epidemic of fulminant hepatitis

1 reference

12 December 2020

Microscopic vascular invasion detected by anti-CD34 immunohistochemistry as a predictor of recurrence of hepatocellular carcinoma after liver transplantation

1 reference

12 December 2020

Clinicopathological differences between hepatitis B viral genotype B- and C-related resectable hepatocellular carcinoma.

1 reference

12 December 2020

Role of hepatitis B virus genotypes and quantitative HBV DNA in metastasis and recurrence of hepatocellular carcinoma

1 reference

12 December 2020

Quantitative correlation of serum levels and tumor expression of vascular endothelial growth factor in patients with hepatocellular carcinoma.

1 reference

12 December 2020

Influence of hepatitis B virus X and core promoter mutations on hepatocellular carcinoma among patients infected with subgenotype C2.

1 reference

12 December 2020

Role of hepatitis B viral load and basal core promoter mutation in hepatocellular carcinoma in hepatitis B carriers

1 reference

12 December 2020

Genotype-specific genomic markers associated with primary hepatomas, based on complete genomic sequencing of hepatitis B virus.

1 reference

12 December 2020

Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers.

1 reference

12 December 2020

Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men.

1 reference

12 December 2020

Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years

1 reference

12 December 2020

A1762T/G1764A mutations of hepatitis B virus, associated with the increased risk of hepatocellular carcinoma, reduce basal core promoter activities.

1 reference

12 December 2020

Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular carcinoma

1 reference

12 December 2020

Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level

1 reference

12 December 2020

Global cancer statistics in the year 2000.

1 reference

12 December 2020

Clinical relevance of hepatitis B viral mutations

1 reference

12 December 2020

Management of hepatocellular carcinoma in Japan: consensus-based clinical practice manual proposed by the Japan Society of Hepatology

1 reference

12 December 2020

High serum vascular endothelial growth factor levels predict poor prognosis after radiofrequency ablation of hepatocellular carcinoma: importance of tumor biomarker in ablative therapies

1 reference

12 December 2020

Prognostic significance of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin in patients with resectable hepatocellular carcinoma after surgery

1 reference

12 December 2020

Realistic expectations for cryoablation of liver tumors

1 reference

12 December 2020

Serum vascular endothelial growth factor predicts venous invasion in hepatocellular carcinoma: a prospective study

1 reference

12 December 2020

Hepatitis B virus mutants and fulminant hepatitis B: fitness plus phenotype

1 reference

12 December 2020

Hepatitis B e antigen and the risk of hepatocellular carcinoma

1 reference

12 December 2020

Circulating vascular endothelial growth factor (VEGF) is a possible tumor marker for metastasis in human hepatocellular carcinoma.

1 reference

12 December 2020

Intrahepatic recurrence after percutaneous radiofrequency ablation of hepatocellular carcinoma: analysis of the pattern and risk factors

1 reference

12 December 2020

Prognostic significance of serum vascular endothelial growth factor and endostatin in patients with hepatocellular carcinoma

1 reference

12 December 2020

Phase II study of gemcitabine and oxaliplatin in combination with bevacizumab in patients with advanced hepatocellular carcinoma

1 reference

12 December 2020

10.1007/S10585-009-9283-6

Identifiers

DOI

1 reference

Dimensions Publication ID

1 November 2017

0 references

1 reference